Wednesday, October 12, 2022 5:00:04 PM
Interesting:
"New study of almost 600,000 deaths in Ohio and Florida shows that registered Republicans had far higher excess-death rates than registered Democrats during the pandemic, with almost all of the gap coming after vaccines were available.
James Surowiecki
@JamesSurowiecki
The study shows there was no difference in excess deaths between Dem and GOP voters in 2018 and early 2020 (control). And there was no real gap pre-vaccine.
But beginning spring 2021, and accelerating w/Delta Republicans began dying at a significantly higher rate. "
So perhaps lesson one is that God looks dimly on those that claim they speak for God, and claim that they know what God wants, and that refuse to take the vaccine shot gift from God?
LOL
"New study of almost 600,000 deaths in Ohio and Florida shows that registered Republicans had far higher excess-death rates than registered Democrats during the pandemic, with almost all of the gap coming after vaccines were available.
James Surowiecki
@JamesSurowiecki
The study shows there was no difference in excess deaths between Dem and GOP voters in 2018 and early 2020 (control). And there was no real gap pre-vaccine.
But beginning spring 2021, and accelerating w/Delta Republicans began dying at a significantly higher rate. "
So perhaps lesson one is that God looks dimly on those that claim they speak for God, and claim that they know what God wants, and that refuse to take the vaccine shot gift from God?
LOL
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
